Blood-Brain Barrier Transport Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014561054
Market Monitor Global
Oct-2021
Life Sciences
108 Pages

This report contains market size and forecasts of Blood-Brain Barrier Transport Drugs in global, including the following market information:
Global Blood-Brain Barrier Transport Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Blood-Brain Barrier Transport Drugs Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Blood-Brain Barrier Transport Drugs companies in 2020 (%)
The global Blood-Brain Barrier Transport Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blood-Brain Barrier Transport Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood-Brain Barrier Transport Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, By Type, 2020 (%)
Carrier-mediated Transport
Receptor-mediated Transport
Absorptive-mediated Transport
Active Efflux Transport
Others

Global Blood-Brain Barrier Transport Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, By Application, 2020 (%)
Alzheimer's Disease
Epilepsy
Parkinson's Disease
Multiple Sclerosis
Hunter's Syndrome
Brain Cancer
Others

Global Blood-Brain Barrier Transport Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Blood-Brain Barrier Transport Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood-Brain Barrier Transport Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Blood-Brain Barrier Transport Drugs revenues share in global market, 2020 (%)
Key companies Blood-Brain Barrier Transport Drugs sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Blood-Brain Barrier Transport Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Blood-Brain Barrier Transport Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood-Brain Barrier Transport Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood-Brain Barrier Transport Drugs Overall Market Size
2.1 Global Blood-Brain Barrier Transport Drugs Market Size: 2021 VS 2027
2.2 Global Blood-Brain Barrier Transport Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Blood-Brain Barrier Transport Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Blood-Brain Barrier Transport Drugs Players in Global Market
3.2 Top Global Blood-Brain Barrier Transport Drugs Companies Ranked by Revenue
3.3 Global Blood-Brain Barrier Transport Drugs Revenue by Companies
3.4 Global Blood-Brain Barrier Transport Drugs Sales by Companies
3.5 Global Blood-Brain Barrier Transport Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Blood-Brain Barrier Transport Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Blood-Brain Barrier Transport Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blood-Brain Barrier Transport Drugs Players in Global Market
3.8.1 List of Global Tier 1 Blood-Brain Barrier Transport Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Blood-Brain Barrier Transport Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Blood-Brain Barrier Transport Drugs Market Size Markets, 2021 & 2027
4.1.2 Carrier-mediated Transport
4.1.3 Receptor-mediated Transport
4.1.4 Absorptive-mediated Transport
4.1.5 Active Efflux Transport
4.1.6 Others
4.2 By Type - Global Blood-Brain Barrier Transport Drugs Revenue & Forecasts
4.2.1 By Type - Global Blood-Brain Barrier Transport Drugs Revenue, 2016-2021
4.2.2 By Type - Global Blood-Brain Barrier Transport Drugs Revenue, 2022-2027
4.2.3 By Type - Global Blood-Brain Barrier Transport Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Blood-Brain Barrier Transport Drugs Sales & Forecasts
4.3.1 By Type - Global Blood-Brain Barrier Transport Drugs Sales, 2016-2021
4.3.2 By Type - Global Blood-Brain Barrier Transport Drugs Sales, 2022-2027
4.3.3 By Type - Global Blood-Brain Barrier Transport Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Blood-Brain Barrier Transport Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Blood-Brain Barrier Transport Drugs Market Size, 2021 & 2027
5.1.2 Alzheimer's Disease
5.1.3 Epilepsy
5.1.4 Parkinson's Disease
5.1.5 Multiple Sclerosis
5.1.6 Hunter's Syndrome
5.1.7 Brain Cancer
5.1.8 Others
5.2 By Application - Global Blood-Brain Barrier Transport Drugs Revenue & Forecasts
5.2.1 By Application - Global Blood-Brain Barrier Transport Drugs Revenue, 2016-2021
5.2.2 By Application - Global Blood-Brain Barrier Transport Drugs Revenue, 2022-2027
5.2.3 By Application - Global Blood-Brain Barrier Transport Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Blood-Brain Barrier Transport Drugs Sales & Forecasts
5.3.1 By Application - Global Blood-Brain Barrier Transport Drugs Sales, 2016-2021
5.3.2 By Application - Global Blood-Brain Barrier Transport Drugs Sales, 2022-2027
5.3.3 By Application - Global Blood-Brain Barrier Transport Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Blood-Brain Barrier Transport Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Blood-Brain Barrier Transport Drugs Market Size, 2021 & 2027
6.2 By Region - Global Blood-Brain Barrier Transport Drugs Revenue & Forecasts
6.2.1 By Region - Global Blood-Brain Barrier Transport Drugs Revenue, 2016-2021
6.2.2 By Region - Global Blood-Brain Barrier Transport Drugs Revenue, 2022-2027
6.2.3 By Region - Global Blood-Brain Barrier Transport Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Blood-Brain Barrier Transport Drugs Sales & Forecasts
6.3.1 By Region - Global Blood-Brain Barrier Transport Drugs Sales, 2016-2021
6.3.2 By Region - Global Blood-Brain Barrier Transport Drugs Sales, 2022-2027
6.3.3 By Region - Global Blood-Brain Barrier Transport Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Blood-Brain Barrier Transport Drugs Revenue, 2016-2027
6.4.2 By Country - North America Blood-Brain Barrier Transport Drugs Sales, 2016-2027
6.4.3 US Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.4.4 Canada Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.4.5 Mexico Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Blood-Brain Barrier Transport Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Blood-Brain Barrier Transport Drugs Sales, 2016-2027
6.5.3 Germany Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.5.4 France Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.5.5 U.K. Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.5.6 Italy Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.5.7 Russia Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.5.9 Benelux Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Blood-Brain Barrier Transport Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Blood-Brain Barrier Transport Drugs Sales, 2016-2027
6.6.3 China Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.6.4 Japan Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.6.5 South Korea Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.6.7 India Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Blood-Brain Barrier Transport Drugs Revenue, 2016-2027
6.7.2 By Country - South America Blood-Brain Barrier Transport Drugs Sales, 2016-2027
6.7.3 Brazil Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.7.4 Argentina Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Blood-Brain Barrier Transport Drugs Sales, 2016-2027
6.8.3 Turkey Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.8.4 Israel Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
6.8.6 UAE Blood-Brain Barrier Transport Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Cyclenium
7.1.1 Cyclenium Corporate Summary
7.1.2 Cyclenium Business Overview
7.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Major Product Offerings
7.1.4 Cyclenium Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Cyclenium Key News
7.2 BioAdvance
7.2.1 BioAdvance Corporate Summary
7.2.2 BioAdvance Business Overview
7.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Major Product Offerings
7.2.4 BioAdvance Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.2.5 BioAdvance Key News
7.3 EIP Pharma
7.3.1 EIP Pharma Corporate Summary
7.3.2 EIP Pharma Business Overview
7.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.3.4 EIP Pharma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.3.5 EIP Pharma Key News
7.4 Bioasis
7.4.1 Bioasis Corporate Summary
7.4.2 Bioasis Business Overview
7.4.3 Bioasis Blood-Brain Barrier Transport Drugs Major Product Offerings
7.4.4 Bioasis Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Bioasis Key News
7.5 Immune Pharmaceuticals
7.5.1 Immune Pharmaceuticals Corporate Summary
7.5.2 Immune Pharmaceuticals Business Overview
7.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Major Product Offerings
7.5.4 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Immune Pharmaceuticals Key News
7.6 AZ Therapies
7.6.1 AZ Therapies Corporate Summary
7.6.2 AZ Therapies Business Overview
7.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Major Product Offerings
7.6.4 AZ Therapies Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.6.5 AZ Therapies Key News
7.7 Palobiofarma
7.7.1 Palobiofarma Corporate Summary
7.7.2 Palobiofarma Business Overview
7.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.4.4 Palobiofarma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Palobiofarma Key News
7.8 Bach Pharma
7.8.1 Bach Pharma Corporate Summary
7.8.2 Bach Pharma Business Overview
7.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.8.4 Bach Pharma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Bach Pharma Key News
7.9 BrainsGate
7.9.1 BrainsGate Corporate Summary
7.9.2 BrainsGate Business Overview
7.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Major Product Offerings
7.9.4 BrainsGate Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.9.5 BrainsGate Key News
7.10 CarThera
7.10.1 CarThera Corporate Summary
7.10.2 CarThera Business Overview
7.10.3 CarThera Blood-Brain Barrier Transport Drugs Major Product Offerings
7.10.4 CarThera Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.10.5 CarThera Key News
7.11 Dainippon Sumitomo Pharma
7.11.1 Dainippon Sumitomo Pharma Corporate Summary
7.11.2 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Business Overview
7.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.11.4 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Dainippon Sumitomo Pharma Key News
7.12 Fluorinov Pharma
7.12.1 Fluorinov Pharma Corporate Summary
7.12.2 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Business Overview
7.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Major Product Offerings
7.12.4 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Fluorinov Pharma Key News
7.13 Fondazione Telethon
7.13.1 Fondazione Telethon Corporate Summary
7.13.2 Fondazione Telethon Blood-Brain Barrier Transport Drugs Business Overview
7.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Major Product Offerings
7.13.4 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Fondazione Telethon Key News
7.14 Minoryx
7.14.1 Minoryx Corporate Summary
7.14.2 Minoryx Business Overview
7.14.3 Minoryx Blood-Brain Barrier Transport Drugs Major Product Offerings
7.14.4 Minoryx Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.14.5 Minoryx Key News
7.15 NewGen Therapeutics
7.15.1 NewGen Therapeutics Corporate Summary
7.15.2 NewGen Therapeutics Business Overview
7.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Major Product Offerings
7.15.4 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales and Revenue in Global (2016-2021)
7.15.5 NewGen Therapeutics Key News
8 Global Blood-Brain Barrier Transport Drugs Production Capacity, Analysis
8.1 Global Blood-Brain Barrier Transport Drugs Production Capacity, 2016-2027
8.2 Blood-Brain Barrier Transport Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Blood-Brain Barrier Transport Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blood-Brain Barrier Transport Drugs Supply Chain Analysis
10.1 Blood-Brain Barrier Transport Drugs Industry Value Chain
10.2 Blood-Brain Barrier Transport Drugs Upstream Market
10.3 Blood-Brain Barrier Transport Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blood-Brain Barrier Transport Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Blood-Brain Barrier Transport Drugs in Global Market
Table 2. Top Blood-Brain Barrier Transport Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Blood-Brain Barrier Transport Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Blood-Brain Barrier Transport Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Blood-Brain Barrier Transport Drugs Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Blood-Brain Barrier Transport Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Blood-Brain Barrier Transport Drugs Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Blood-Brain Barrier Transport Drugs Product Type
Table 9. List of Global Tier 1 Blood-Brain Barrier Transport Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blood-Brain Barrier Transport Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Cyclenium
BioAdvance
EIP Pharma
Bioasis
Immune Pharmaceuticals
AZ Therapies
Palobiofarma
Bach Pharma
BrainsGate
CarThera
Dainippon Sumitomo Pharma
Fluorinov Pharma
Fondazione Telethon
Minoryx
NewGen Therapeutics

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE